Perlmutter Cancer Center at NYU Langone

02/21/2026

02/20/2026

Immunotherapy has transformed cancer care—but researchers are working to make it even more precise and effective.

A team led by Michelle Krogsgaard, PhD, studies how immune cells recognize cancer—and why some tumors escape detection. By identifying new cancer-specific markers and uncovering how tumors hide from the immune system, researchers can help pave the way for safer, more personalized treatments.

Learn about their latest findings: https://nyulangone.org/news/pinpointing-new-cancer-targets-immune-systems-strike-force

02/19/2026

02/19/2026

Interested in learning the latest on cancer prevention, early detection, screening, treatment options, survivorship care and more?

Subscribe to our community newsletter to learn about free educational events open to the public and the latest news from Perlmutter Cancer Center: https://i.nyulangone.org/cxo

02/09/2026

We’re excited to welcome Daniel Gomez, MD, MBA, as the new Chair of the Department of Radiation Oncology at Perlmutter Cancer Center at NYU Langone!

Dr. Gomez is a leading physician-scientist in radiation oncology, with specialized expertise in treating oligometastatic cancers, a complex form of stage IV disease that requires close collaboration across multiple specialties. His work has largely focused on lung cancer and the role of radiation therapy in oligometastatic disease, and he has led or co-led numerous clinical trials and major national studies that have helped shape today’s standards of care in thoracic oncology.

In his new role, Dr. Gomez will guide multidisciplinary teams of physicians and researchers as they advance innovative research and deliver highly personalized radiation therapy, tailoring treatment plans to each patient’s clinical history, imaging, and molecular profile.

“I am very honored to join NYU Langone’s Perlmutter Cancer Center,” Dr. Gomez says. “There is an incredible amount of energy and enthusiasm throughout the medical center, which is inspiring in the mission to improve cancer care for our patients.”

Learn more about Dr. Gomez: https://bit.ly/3ZZLIno

02/04/2026

Physical activity and exercise can have profound benefits on strength and flexibility, sleep quality, and mood. But, did you know that it does not require a trip to your neighborhood gym or local facility? Reducing sitting time at home for a little as 5-10 minutes can have a significant impact on your health, wellness, and happiness. Join Rusk Rehabilitation’s Amanda Palmeri, PT, DPT to learn simple and easy ways to go from couch surfer to energized and unstoppable!

All are welcome. RSVP: https://bit.ly/4rkGPkm

01/28/2026

We’re excited to announce that Anirban Maitra, MD has been appointed the new director of Perlmutter Cancer Center at NYU Langone.

A pre-eminent physician-scientist whose work has widely influenced the field of pancreatic cancer research, Dr. Maitra joined NYU Langone in August 2025 as co-director of our Gastrointestinal (GI) Cancer Center, which brings together the collective expertise of our GI cancer experts to deliver care for patients with GI cancer or precancerous conditions. Prior to joining NYU Langone, he served as the inaugural scientific director of the Pancreatic Cancer Research Center at MD Anderson Cancer Center, where his work focused on early detection and biomarker development, two key avenues for effective cancer treatments.

“Dr. Maitra is a proven leader in oncology, and his experience guiding integrated, multidisciplinary teams makes him an outstanding choice to direct Perlmutter Cancer Center,” says Alec C. Kimmelman, MD, PhD, Dean of NYU Grossman School of Medicine and CEO of NYU Langone Health. “He brings a strong record of clinical and scientific achievement, a deep commitment to advancing cancer research, and the vision needed to help drive Perlmutter Cancer Center’s continued growth and impact on patients and families.”

“I am both humbled and excited to accept this opportunity to lead the Perlmutter Cancer Center,” Dr. Maitra says. “The integrated nature of this institution gives us so many opportunities to develop our understanding and agility to more rapidly develop new cancer therapies.”

Learn more about Dr. Maitra: https://bit.ly/4rl4BwR

01/27/2026

A gynecologic oncologist at NYU Langone Health who treats patients with cervical cancer shares the warning signs she looks for in her own body.

12/23/2025

Join us for a three-part patient-driven webinar series that will deliver the most important clinical and scientific treatment breakthroughs for myeloma, lymphoma and leukemia presented at the latest American Society of Hematology (ASH) Annual Meeting in December 2025.

This series will uncover the latest findings in blood cancer care, translating cutting-edge data into practical insights for patients and caregivers. Leading experts from Perlmutter Cancer Center’s Center for Blood Cancers are partnering with Blood Cancer United to highlight clinical trial updates, emerging treatment strategies, and implications for disease management for patients in 2025 and beyond.

All are welcome. Register: https://i.nyulangone.org/y49

12/18/2025

Missed out on this program? Check out the recording: https://youtu.be/E2p7i_vHXas

Even after cancer treatment ends, the fear that it might return can feel heavy and persistent. Join Karen Sheinkopf, LCSW and Dr. Michael Shusterman to learn ways you can navigate the emotional challenges of life after diagnosis and how to find support, hope and meaning in survivorship. This talk will highlight how to cope with fear of recurrence – focusing on how it can impact your daily life and offering practical strategies to manage uncertainty. They’ll also discuss “scanxiety” — the stress and worry around follow-up scans—and how it can affect your health and well-being, even years after remission.

All are welcome. RSVP: https://i.nyulangone.org/b9u